U. Margaretha Wallon

654 total citations
15 papers, 549 citations indexed

About

U. Margaretha Wallon is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, U. Margaretha Wallon has authored 15 papers receiving a total of 549 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cancer Research, 5 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in U. Margaretha Wallon's work include Protease and Inhibitor Mechanisms (9 papers), Peptidase Inhibition and Analysis (5 papers) and Blood Coagulation and Thrombosis Mechanisms (5 papers). U. Margaretha Wallon is often cited by papers focused on Protease and Inhibitor Mechanisms (9 papers), Peptidase Inhibition and Analysis (5 papers) and Blood Coagulation and Thrombosis Mechanisms (5 papers). U. Margaretha Wallon collaborates with scholars based in United States, Canada and Sweden. U. Margaretha Wallon's co-authors include Christopher M. Overall, Bjorn Steffensen, Heather F. Bigg, Eric M. Tam, Charlotte Morrison, Clive J. Roberts, Olle Heby, G. Angus McQuibban, Yves A. DeClerck and Tim T Y Lau and has published in prestigious journals such as Journal of Biological Chemistry, Cancer Research and FEBS Letters.

In The Last Decade

U. Margaretha Wallon

15 papers receiving 535 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
U. Margaretha Wallon United States 10 395 286 205 150 112 15 549
Jean-Marc Lewalle Belgium 9 276 0.7× 213 0.7× 241 1.2× 94 0.6× 132 1.2× 11 524
Nancy C.M. Caterina United States 9 263 0.7× 184 0.6× 112 0.5× 103 0.7× 55 0.5× 9 354
Justin Mitchell United States 3 175 0.4× 180 0.6× 174 0.8× 52 0.3× 99 0.9× 3 407
Meng‐Huee Lee United Kingdom 16 391 1.0× 323 1.1× 266 1.3× 137 0.9× 108 1.0× 20 636
Bowden Gt United States 10 221 0.6× 201 0.7× 242 1.2× 35 0.2× 129 1.2× 14 497
MJ Duffy Ireland 5 302 0.8× 220 0.8× 234 1.1× 83 0.6× 103 0.9× 8 503
Kazuaki Fushimi Japan 15 131 0.3× 135 0.5× 333 1.6× 18 0.1× 28 0.3× 22 486
Jonathan Waxman United Kingdom 7 269 0.7× 257 0.9× 311 1.5× 29 0.2× 78 0.7× 17 633
Mehdi El Hour Belgium 5 127 0.3× 127 0.4× 174 0.8× 46 0.3× 83 0.7× 5 345

Countries citing papers authored by U. Margaretha Wallon

Since Specialization
Citations

This map shows the geographic impact of U. Margaretha Wallon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by U. Margaretha Wallon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites U. Margaretha Wallon more than expected).

Fields of papers citing papers by U. Margaretha Wallon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by U. Margaretha Wallon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by U. Margaretha Wallon. The network helps show where U. Margaretha Wallon may publish in the future.

Co-authorship network of co-authors of U. Margaretha Wallon

This figure shows the co-authorship network connecting the top 25 collaborators of U. Margaretha Wallon. A scholar is included among the top collaborators of U. Margaretha Wallon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with U. Margaretha Wallon. U. Margaretha Wallon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
DuHadaway, James B., Alexander J. Muller, Lisa D. Laury‐Kleintop, et al.. (2024). Abstract LB355: Cryo-immune vaccination (CIV) by SYNC-T therapy: Preclinical modeling of a novel device-multidrug immunotherapeutic approach to eradicate advanced metastatic cancers. Cancer Research. 84(7_Supplement). LB355–LB355. 1 indexed citations
2.
3.
Wallon, U. Margaretha, et al.. (2015). Abstract P6-08-54: TIMP-4 is a prognostic and predictive marker in triple-negative breast cancers. Cancer Research. 75(9_Supplement). P6–8. 1 indexed citations
4.
Donover, Preston S., et al.. (2010). Development of a monoclonal antibody that specifically detects tissue inhibitor of metalloproteinase‐4 (TIMP‐4) in formalin‐fixed, paraffin‐embedded human tissues. Journal of Cellular Biochemistry. 110(5). 1255–1261. 1 indexed citations
5.
Keshgegian, Albert A., et al.. (2009). Tissue Inhibitor of Metalloproteinase-4 Is Elevated in Early-Stage Breast Cancers with Accelerated Progression and Poor Clinical Course. American Journal Of Pathology. 175(3). 940–946. 20 indexed citations
6.
Wallon, U. Margaretha & Thomas G. O’Brien. (2004). Polyamines modulate carcinogen-induced mutagenesis in vivo. Environmental and Molecular Mutagenesis. 45(1). 62–69. 5 indexed citations
7.
Overall, Christopher M., Eric M. Tam, G. Angus McQuibban, et al.. (2000). Domain Interactions in the Gelatinase A·TIMP-2·MT1-MMP Activation Complex. Journal of Biological Chemistry. 275(50). 39497–39506. 82 indexed citations
8.
Overall, Christopher M., et al.. (1999). Identification of the Tissue Inhibitor of Metalloproteinases-2 (TIMP-2) Binding Site on the Hemopexin Carboxyl Domain of Human Gelatinase A by Site-directed Mutagenesis. Journal of Biological Chemistry. 274(7). 4421–4429. 68 indexed citations
9.
Overall, Christopher M., Heather F. Bigg, Tim T Y Lau, et al.. (1999). Identification of the TIMP‐2 Binding Site on the Gelatinase A Hemopexin C‐Domain by Site‐Directed Mutagenesis and the Yeast Two‐Hybrid System. Annals of the New York Academy of Sciences. 878(1). 747–753. 9 indexed citations
10.
Wallon, U. Margaretha & Christopher M. Overall. (1997). The Hemopexin-like Domain (C Domain) of Human Gelatinase A (Matrix Metalloproteinase-2) Requires Ca2+ for Fibronectin and Heparin Binding. Journal of Biological Chemistry. 272(11). 7473–7481. 96 indexed citations
11.
Wallon, U. Margaretha, et al.. (1996). Expression of 72-kDa gelatinase (matrix metailloproteinase-2) in the developing mouse craniofacial complex. Archives of Oral Biology. 41(12). 1109–1119. 23 indexed citations
12.
Steffensen, Bjorn, U. Margaretha Wallon, & Christopher M. Overall. (1995). Extracellular Matrix Binding Properties of Recombinant Fibronectin Type II-like Modules of Human 72-kDa Gelatinase/Type IV Collagenase. Journal of Biological Chemistry. 270(19). 11555–11566. 186 indexed citations
13.
Wallon, U. Margaretha, Lo Persson, & Olle Heby. (1995). Regulation of ornithine decarboxylase during cell growth. Changes in the stability and translatability of the mRNA, and in the turnover of the protein. Molecular and Cellular Biochemistry. 146(1). 39–44. 18 indexed citations
14.
Wallon, U. Margaretha, et al.. (1994). Polyamine‐dependent expression of the matrix metalloproteinase matrilysin in a human colon cancer—derived cell line. Molecular Carcinogenesis. 11(3). 138–144. 24 indexed citations
15.
Wallon, U. Margaretha, Lo Persson, & Olle Heby. (1990). Superinduction of ornithine decarboxylase (ODC) by actinomycin D is due to stimulation of ODC mRNA translation. FEBS Letters. 268(1). 161–164. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jean-Marc Lewalle Breakdown of academic impact, for papers by Nancy C.M. Caterina Breakdown of academic impact, for papers by Justin Mitchell Breakdown of academic impact, for papers by Meng‐Huee Lee Breakdown of academic impact, for papers by Bowden Gt Breakdown of academic impact, for papers by MJ Duffy Breakdown of academic impact, for papers by Kazuaki Fushimi Breakdown of academic impact, for papers by Jonathan Waxman Breakdown of academic impact, for papers by Mehdi El Hour
Rankless by CCL
2026